Conference Coverage

Genomic Research Could Yield Preventive Therapies for SUDEP


 

References

Adenosine receptors may be another target for intervention. When researchers blocked adenosine deaminase or adenosine kinase in mouse models of SUDEP, the mice’s seizures ended more quickly, but the mice had an increased risk of death. Treatment at the onset of the seizure, rather than during the seizure, with an adenosine receptor antagonist may improve survival, concluded Dr. Goldman.

—Erik Greb
Senior Associate Editor

Pages

Recommended Reading

Features of Lennox-Gastaut syndrome of unknown cause described in large study
MDedge Neurology
Funding for epilepsy research lags behind Alzheimer’s, autism
MDedge Neurology
Fine-Tuning the Ketogenic Diet May Benefit Children With Epilepsy
MDedge Neurology
Immunotherapy showed promise in predicting autoimmune-related epilepsy
MDedge Neurology
Task force identifies minimum requirements to diagnose psychogenic seizures
MDedge Neurology
FDA approves eslicarbazepine as an adjunctive partial seizure treatment
MDedge Neurology
FDA approves neurostimulator device for treatment-resistant epilepsy
MDedge Neurology
Fine-Tuning the Ketogenic Diet May Benefit Children With Epilepsy—And Other News From the Child Neurology Society Meeting
MDedge Neurology
Favorable Immunotherapy Response May Indicate Autoimmune Epilepsy
MDedge Neurology
Task Force Identifies Requirements for Diagnosing Psychogenic Seizures
MDedge Neurology